Technology ID
TAB-1720

HIV Monoclonal Antibodies

E-Numbers
E-109-2008-0
Lead Inventor
Moss, Bernard (NIAID)
Co-Inventors
Earl, Patricia (NIAID)
Broder, Christopher
Doms, Robert
Applications
Research Materials
Therapeutic Areas
Infectious Disease
Development Status
  • Murine hybridomas available
  • T32 mAb available
Lead IC
NIAID
ICs
NIAID
This technology describes several hybridomas that produce monoclonal antibodies (mAbs) useful in HIV research applications. The mAbs are specific for either gp41 or gp120. In particular, the hybridomas producing mAbs designated D19, D56, M12, T8 and T24 (all anti-gp120), and T32 and T33 (gp41 specific) were found to be of particular utility. Additional hybridomas expressing mAbs disclosed in the publications may also be available.
Commercial Applications
  • HIV research

Request More Info

Licensing Contact:
Hurley, Benjamin
benjamin.hurley@nih.gov

Related Inventions

  • E-200-1993-1

Publications

Collaborations

  • Collaboration

Collaboration Description

  • The National Institute of Allergy and Infectious Dieases, Laboratory of Viral Diseases, is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize HIV Monoclonal Antibodies. Please contact either Michael Pizali or Dana Hsu at 301-496-2644 for more information.
Date Published